Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

MEBO Metabolic Malodor Survey (international) for Dr Hazen click here
click to Read more/less

survey for ANYONE who identifies with METABOLIC MALODOR

begun : Oct20
end : no ending for now

Regular readers will know that Dr Stan Hazen et al at Cleveland Clinic are developing a TMA-blocker pill, as they proposed in a 2011 paper that TMAO is a factor in CVD. Recently Dr Hazen and colleagues contacted MEBO as they have always thought they could also help with TMAU. This survey is to give them an idea of the 'state of the community'. It is a "version 1". They may not even look (though they have access permission), but it could be useful to give them an overview of the community

MEBO had a zoom call with Dr Hazen and his team in October. Another zoom call is planned when they have time

This is a GOOGLE FORMS survey

short url for survey :

current participants : 113 (update 18dec20)

Monday, October 26, 2009

Expert overseeing MEBO Research Studies

we are most grateful to Dr. Irene Gabashvili, PhD, for overseeing MEBO Research's exploratory trials. She brings with her years of experience in biomedical industry and academia. Dr. Irene is the founder of Aurametrix, which she continues to develop as she works very closely with the MEBO community to address our needs.  She heads the MEBO directorship as we explore new groundbreaking research possibilities in an effort to develop accurate diagnosis, treatment and a cure to the various types of body and breath odor conditions.

Throughout her career, Dr. Gabashvili has been interested in the molecular, cellular, and physiological mechanisms of health and disease. She developed models and data analysis approaches and experimentally studied physics of microbial infection, chemistry of light and radiation effects on living matter, plant enzymes, structural basis of antibiotic resistance, human pathologies dependent on variation in mitochondrial genes, development of sensory apparatus and aging, and inheritance and environmental factors contributing to the development of diseases.

Dr. Gabashvili was overseeing exploratory trials and data mining studies in the past, working with medical doctors and supervising MD students. For example, she studied analysis of blood biomarkers to determine patterns of longevity at the Center of Genetic Ecology. She worked in microbiology, molecular biology, biochemistry and biophysics labs and was utilizing state-of-the-art techniques and instrumentation to characterize macro- and micro-molecules causing or protecting from disease. She continues to collaborate with experimental labs, in particular employing novel chromatographic and mass spectrometry approaches to identify disease biomarkers.

Dr. Gabashvili has developed software tools and IT infrastructure to support research and clinical processes. She worked with and for Hewlett Packard, Merck, Pfizer, Johnson & Johnson, Novartis, etc. Her academic partnerships include renowned scientists and clinicians from Stanford and Harvard Universities.

Dr. Gabashvili demonstrated a concerted interest in applying her wealth of knowledge to MEBO's research aims for the betterment of our community. She is especially interested in clinical nutrition and the complex relationship between the human immune system with trillions of microbes populating human beings. You can contact her directly by e-mailing to Irene at

Irene Gabashvili, PhD
Scientific Director, MEBO Research
Founder of Aurametrix &

See Slideshow presentation "Microbes and Us"
Alphabetical List of Pathogenic Bacteria


María de la Torre
Founder and Executive Director

A Public Charity (MEBO Brasil)
The MEBO Blog (English)
El Blog de MEBO (español) 
NORD Member Organization
EURORDIS Member Organisation 

SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online
at no extra cost to you.
MEBO gets small commission from Amazon.

Please use your credit card to make your donation to MEBO.

Subscribe for latest posts : Enter your email address:

Delivered by FeedBurner

A EURORDIS and NORD Member Organization


Post a Comment